Griffeth W Tully, MD
Emergency Medicine · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tully’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A60035 · Current
Licensed to practise in California · since 1996 · expires 2027-10-31 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$58,339
Medicare paid this office $58,339 for 426 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 153 | $17,688 | $111 |
| New patient visit (45+ min) | 127 | $16,921 | $133 |
| Short return visit (20+ min) | 72 | $5,463 | $74 |
| New patient visit (30+ min) | 50 | $4,014 | $80 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 26 | $3,634 | $140 |
See all 12 services
| Return visit (30+ min) | 153 | $17,688 | $111 |
| New patient visit (45+ min) | 127 | $16,921 | $133 |
| Short return visit (20+ min) | 72 | $5,463 | $74 |
| New patient visit (30+ min) | 50 | $4,014 | $80 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 26 | $3,634 | $140 |
| New patient visit (60+ min) | 14 | $2,162 | $154 |
| Long return visit (40+ min) | 13 | $1,960 | $151 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $855 | $50 |
| Short return visit | 14 | $844 | $50 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $243 | $16 |
| Injection of drug or substance under skin or into muscle | 13 | $202 | $13 |
| Urinalysis, manual test | 29 | $99 | $3 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
426 Original Medicare patients in 2024. Average age 78 · Women 59% · Also on Medicaid 9% · Health risk score 1.02. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 68% · Coronary heart disease 24% · Diabetes 23% · Chronic kidney disease 22% · Atrial fibrillation 18% · Depression 15% · Heart failure 13% · Cancer 13% · COPD 9% · Dementia 7% · Stroke 7%.
The office billed $223,277, Medicare allowed $83,566 and paid $58,339; for 718 services of 54 kinds; $228 of it was for drugs given in the office and $58,111 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 426 | 718 | 78 | 1.02 | $223,277 | $58,339 |
| 2023 | 370 | 684 | 77 | 1.05 | $196,944 | $52,089 |
| 2022 | 453 | 1,153 | 77 | 0.94 | $194,997 | $56,954 |
| 2021 | 287 | 573 | 77 | 1.08 | $113,940 | $36,776 |
| 2020 | 171 | 650 | 77 | 1.30 | $68,103 | $16,875 |
| 2019 | 351 | 2,546 | 77 | 1.17 | $135,680 | $32,930 |
| 2018 | 255 | 696 | 76 | 1.14 | $78,600 | $22,437 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| New patient visit (45+ min) | 107 | $13,391 | $125 |
| Return visit (30+ min) | 114 | $12,548 | $109 |
| Short return visit (20+ min) | 65 | $5,070 | $77 |
| New patient visit (60+ min) | 22 | $4,044 | $184 |
| New patient visit (30+ min) | 46 | $3,953 | $86 |
| Long return visit (40+ min) | 14 | $2,339 | $167 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 13 | $1,817 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 23 | $1,156 | $50 |
| Short return visit | 15 | $852 | $53 |
| Injection of drug or substance under skin or into muscle | 20 | $331 | $13 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $194 | $16 |
| Urinalysis, manual test | 31 | $106 | $3 |
2022: 12 services
| Return visit (30+ min) | 138 | $16,061 | $113 |
| Short return visit (20+ min) | 122 | $10,147 | $81 |
| New patient visit (30+ min) | 81 | $6,962 | $86 |
| New patient visit (45+ min) | 27 | $3,940 | $146 |
| Long return visit (40+ min) | 23 | $3,853 | $168 |
| New patient visit (15+ min) | 43 | $2,957 | $69 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 42 | $2,176 | $51 |
| Short return visit | 17 | $899 | $53 |
| Injection of drug or substance under skin or into muscle | 27 | $391 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $286 | $12 |
| Urinalysis, manual test | 38 | $131 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 17 | $27 | None |
2021: 11 services
| Return visit (30+ min) | 120 | $14,430 | $118 |
| Short return visit (20+ min) | 88 | $7,576 | $85 |
| New patient visit (30+ min) | 40 | $3,897 | $97 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 37 | $1,898 | $51 |
| New patient visit (15+ min) | 24 | $1,417 | $59 |
| Short return visit | 13 | $679 | $52 |
| Injection of drug or substance under skin or into muscle | 24 | $330 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $208 | $14 |
| Urinalysis, manual test | 28 | $97 | $3 |
| Insertion of needle into vein for collection of blood sample | 11 | $33 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $18 | None |
2020: 6 services
| Return visit (30+ min) | 83 | $7,995 | $92 |
| Short return visit (20+ min) | 39 | $2,538 | $62 |
| New patient visit (30+ min) | 26 | $1,750 | $67 |
| New patient visit (15+ min) | 16 | $777 | $49 |
| Injection of drug or substance under skin or into muscle | 14 | $172 | $11 |
| Urinalysis, manual test | 17 | $62 | $3 |
2019: 10 services
| Return visit (30+ min) | 192 | $17,011 | $86 |
| Short return visit (20+ min) | 84 | $5,028 | $58 |
| New patient visit (30+ min) | 31 | $2,548 | $82 |
| Short return visit | 20 | $950 | $43 |
| Injection of drug or substance under skin or into muscle | 26 | $476 | $16 |
| New patient visit (15+ min) | 11 | $438 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $312 | $16 |
| Urinalysis, manual test | 35 | $119 | $3 |
| Insertion of needle into vein for collection of blood sample | 31 | $91 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $18 | None |
2018: 5 services
| Return visit (30+ min) | 124 | $11,743 | $94 |
| Short return visit (20+ min) | 117 | $7,753 | $66 |
| Injection of drug or substance under skin or into muscle | 13 | $288 | $21 |
| Urinalysis, manual test | 25 | $85 | $3 |
| Insertion of needle into vein for collection of blood sample | 13 | $38 | $3 |
Medicaid work
$842 in 2019
Medicaid paid $842 for 13 billed services this clinician did in 2019, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $842 |
| 2019 | 13 | 1 | 13 | $842 |
Drugs they prescribed that Part D paid
$6,501
Pharmacies billed $6,501 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
309 generic and fewer than 11 brand-name prescriptions · $6,501 in drug cost · 159 antibiotic prescriptions to 118 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 25 | $1,429 | $57 |
| Albuterol Sulfate Hfa | 24 | $502 | $21 |
| Diclofenac | 13 | $198 | $15 |
| Doxycycline Monohydrate | 22 | $182 | $8 |
| Cephalexin | 24 | $165 | $7 |
See all 12 drugs
| Paxlovid | 25 | $1,429 | $57 |
| Albuterol Sulfate Hfa | 24 | $502 | $21 |
| Diclofenac | 13 | $198 | $15 |
| Doxycycline Monohydrate | 22 | $182 | $8 |
| Cephalexin | 24 | $165 | $7 |
| Nitrofurantoin Mono-Macro | 17 | $158 | $9 |
| Azithromycin | 23 | $130 | $6 |
| Amoxicillin-Clavulanate Potass | 14 | $118 | $8 |
| Fluticasone Propionate | 11 | $79 | $7 |
| Prednisone | 28 | $70 | $3 |
| Amoxicillin | 23 | $69 | $3 |
| Naproxen | 22 | $52 | $2 |
Year by year
| 2024 | 376 | 259 | None | None | $6,501 |
| 2023 | 316 | 217 | None | 9% | $12,220 |
| 2022 | 303 | 223 | None | 7% | $5,835 |
| 2021 | 157 | 130 | None | None | $2,959 |
| 2020 | 89 | 75 | None | 13% | $3,006 |
| 2019 | 197 | 150 | 7% (14) | None | $5,568 |
| 2018 | 136 | 104 | None | None | $3,598 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Albuterol Sulfate Hfa | 17 | $529 | $31 |
| Cephalexin | 23 | $273 | $12 |
| Doxycycline Monohydrate | 19 | $238 | $13 |
| Diclofenac | 11 | $213 | $19 |
| Nitrofurantoin Mono-Macro | 15 | $205 | $14 |
| Paxlovid (Eua) | 19 | $183 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $136 | $9 |
| Amoxicillin | 14 | $70 | $5 |
| Azithromycin | 15 | $55 | $4 |
| Naproxen | 19 | $55 | $3 |
| Prednisone | 14 | $36 | $3 |
2022: 9 drugs
| Cephalexin | 38 | $352 | $9 |
| Nitrofurantoin Mono-Macro | 17 | $291 | $17 |
| Diclofenac | 13 | $277 | $21 |
| Paxlovid (Eua) | 29 | $275 | $9 |
| Amoxicillin-Clavulanate Potass | 21 | $178 | $8 |
| Ciprofloxacin | 12 | $92 | $8 |
| Sulfamethoxazole-Trimethoprim | 12 | $60 | $5 |
| Naproxen | 16 | $54 | $3 |
| Prednisone | 14 | $45 | $3 |
2021: 4 drugs
| Albuterol Sulfate Hfa | 11 | $411 | $37 |
| Cephalexin | 13 | $140 | $11 |
| Amoxicillin-Clavulanate Potass | 15 | $127 | $8 |
| Naproxen | 12 | $41 | $3 |
2020: 1 drug
| Cephalexin | 17 | $75 | $4 |
2019: 5 drugs
| Ventolin Hfa | 17 | $973 | $57 |
| Cephalexin | 16 | $122 | $8 |
| Azithromycin | 20 | $102 | $5 |
| Prednisone | 17 | $61 | $4 |
| Acetaminophen-Codeine | 12 | $56 | $5 |
2018: 2 drugs
| Azithromycin | 18 | $98 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $68 | $6 |
Money from drug and device companies
$108,861 in 2023
| 2023 | 1 | 1 | $108,861 | $108,861 |
| 2022 | 1 | 4 | $3,456 | $3,456 |
| 2021 | 1 | 3 | $1,185 | $1,185 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Triton Canister System | $108,861 | 1 payment
|
See the published payment
| Stryker | Royalties · 2023-05-26 | Triton Canister System | $108,861 |
See earlier years (2022, 2021)
2022: $3,456
| Stryker | Triton Canister System | $3,456 | 4 payments
|
2021: $1,185
| Stryker | Ezout | $1,185 | 3 payments
|
Professional record
- NPI
- 1053447532
- Licence
- CA A60035California A60035: Current · expires 2027-10-31
- Trained
- New York Medical College, 1994
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207PE0004X (207PE0004X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-02-26
- NPI last updated
- 2020-02-18
- NPI record certified
- 2020-02-18
This is when the NPI record was last certified, not a medical board exam.